Laserfiche WebLink
FROM FAX NO. :2092394919 Oun. 28 2004 09:58AM P3 <br />FROM PATI 1 P ; CCARDra Parr. Nr3, j a.n. 14 2034 04: 2FFI M Pe. <br />Waste Pharmaceutical Disposal Program <br />1. i Curdy ontainer labeled on the toacauticalG must bp p and sides with the words "Ginerate Only",atod from other t"M of medical wastes contained <br />2, For asecut ty measures to avert u iatithorized access to waw pharmaceuticals durblig the <br />storagelaccumulation process, commingle all waste~ pharmaa; euilea7Etls, remove dos" frorri <br />bliatsr packs or viaiaa, or tithe rMse "a.du!trate the drug -j." <br />3. The waste pharmaceuticals most be placed, into either the Kendall Pharma Satatyf contairwr-or <br />a plastic liner, a red bicahazarel liner cannp tib, and properly closed (liner tied at tho <br />top, uss of tie straga atc.) prior to doiAg els followw <br />Fpr rivQr P'laoe the Kon. 4A co. ntMnPr in your scoured storage MC <br />4. The, waste pharrmaceuttc als secondary c ipritalnsr eannot bra' a container designated as a <br />reguiated medical waste container. Thera c*nnat be any R markings or [abaft on the <br />Kendall contaioar of the secondaN container., <br />PRWEDURES, <br />Determine that the re to pharm acoutidalas caro not a "Hmardous Waste". tjr:der Federal and <br />State law, cartain pharrraaMUUr;ais, if classified' as waste, also qualify as a 'hazardous waste'. and <br />must be ca efuliy managed in n d's, reni ma�l)ner. Such wastes may be a legally Prohibited <br />ttazardcaus waste as a result of haagcy of taiOvring characteristics-, (1) corroslvify (2) <br />igritability, ($) toxicity andlor (4) reactivity: I.. addition, certain pharmaceuticals contain constituent <br />elements, rerrrpcunds or feature.9 that have br„en doclarrd hazardous by Federal or strata reagutaatars, <br />and as such qualify as a 'listed' hazwdous wr.stF. Fxsmples of these kinds of ..waste are induded in <br />the attw-,ho naplzs' of RCCA Hazac�trats 'frieamaceut:tai Waste. Pecaua a pharmscowtir als vary <br />and ;heir fofmulation amd manufacty gharige Oyer time, t e attached 'list is notinte'3nded to be <br />exraa;jsdy@ ar.d Stericyde disclaims the ur,' ecy anchor completeness of this . st. YOU k4UST <br />REVIEW AND EXAMINE' ANY AND' ALL iNFORMATION E�Ft®�i��i? tP�ipki YOUR <br />pp}}4RMACEUTICAi_S TO DETERMINt•. IIER THE PHARMCEMCAL 114 QUESTION IS R <br />HAzARDWS WASTE, if you are in dbupt, W"i2ct. the supplier yr n rtt4fmturer of the <br />pharmaceutical in question before cl-ias4ingI the matter as wS$te. Federal and state low requires <br />tiimt the GENERATORS am resooraai�e 4or the groper cid • n of wastes prior to <br />disposal. N you have hazardous osmate pah�rmaceutic,�alS, eome6l your lo*al h rdous waste <br />provider', STE_ �tICY , . iVCii ACCEPT HAZARDOUS 5. <br />3. Determine that the waste pharma"plic* are not "Controlled Ss". The United States <br />lag Enforcement Agency strey regUa$t&a contro!ted subsianc and #tae daepossl and destruction of <br />these substances must be carefully managed end daaeurrtertt d, Oonsult v�ritrith the supplier or <br />rl am.,facturer if you have any doubt about the pEA status of any sutastanre. STElt1CYCLE CANk T <br />ACCi:PT �- Ci Cir 1 <br />i 3. oetermrre that time weate phaa aceuticals asp not 'Redloactiven. Certain pharrnsoeuticais, <br />e,$peclaliy those utilivtd in certain cancer tTeatrnents and related treatments contain radioactive <br />f isotopes. These rn riais Sm regut9t10 by Federal 2nd Mata Iaws and must be handled according:y. <br />Consult )&qh the supplier or manufacturer ifyou* have any doubt about the radioactive nature of a <br />i substanax. 8 tERIOYO>i- hI <br />OT AC PT R_ ArildA iVi» FIAT SAL . <br />i <br />Rx a?rbtoce — BE'l <br />Page 2 of a3 <br />